跳转至内容
Merck
CN
  • Effect of sodium hyaluronate on mucociliary clearance after functional endoscopic sinus surgery.

Effect of sodium hyaluronate on mucociliary clearance after functional endoscopic sinus surgery.

European annals of allergy and clinical immunology (2013-07-19)
M Gelardi, A V N Guglielmi, N De Candia, E Maffezzoni, P Berardi, N Quaranta
摘要

To determine the effect of intranasal sodium hyaluronate on mucociliary clearance time following functional endoscopic sinus surgery in patients with nasal polyposis. Randomized, controlled, blinded study. Thirty-six patients with grade II nasal polyposis undergoing functional endoscopic sinus surgery received intranasal sodium hyaluronate 9 mg twice daily or saline for 30 days commencing on the second day after surgery. Ciliary mucous transport time was assessed using charcoal powder and saccharin administered during rhinoscopy. Other outcomes included changes in symptoms, endoscopic appearance of the nasal mucosa, and tolerability. Patients receiving sodium hyaluronate had a significantly faster mucociliary clearance time at 1 month compared with controls (14.3 +/- 2.5 vs. 23.6 +/- 3.3 minutes; p = 0.000). Furthermore, sodium hyaluronate recipients experienced a lower incidence of rhinorrhea, less nasal obstruction and a lower incidence of exudate on endoscopy than control subjects at 1 month (all p < 0.05). Sodium hyaluronate was well tolerated in patients following functional endoscopic sinus surgery. The use of intranasal sodium hyaluronate in patients undergoing functional endoscopic sinus surgery for nasal polyposis augmented the improvement in mucociliary clearance observed following this procedure and improved several clinical and endoscopic parameters. These data provide encouraging evidence of the beneficial effects of sodium hyaluronate in the care of patients undergoing functional endoscopic sinus surgery with which to continue the development of the product for this indication.

材料
Product Number
品牌
产品描述

Sigma-Aldrich
透明质酸 钠盐 来源于马链球菌, bacterial glycosaminoglycan polysaccharide
Sigma-Aldrich
透明质酸 钠盐 来源于公鸡鸡冠, avian glycosaminoglycan polysaccharide
Sigma-Aldrich
透明质酸 钠盐 来源于牛玻璃体液
Sigma-Aldrich
透明质酸 钠盐 来源于马链球菌, mol wt 8,000-15,000
透明质酸钠, BRP, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
透明质酸 钠盐 来源于马链球菌, mol wt 1,000,000-1,250,000
Sigma-Aldrich
透明质酸 钠盐 来源于兽疫链球菌, bacterial glycosaminoglycan polysaccharide
Sigma-Aldrich
透明质酸 钠盐 来源于马链球菌, mol wt 1,500,000-1,750,000
Sigma-Aldrich
透明质酸 钠盐 来源于马链球菌, mol wt 30,000-50,000
Sigma-Aldrich
透明质酸 钠盐 来源于马链球菌, mol wt 2,000,000-2,400,000
Sigma-Aldrich
透明质酸 钠盐 来源于马链球菌, mol wt 1,200
Sigma-Aldrich
透明质酸 钠盐 来源于马链球菌, mol wt 300,000-500,000
Sigma-Aldrich
透明质酸 钠盐 来源于马链球菌, mol wt 10,000-30,000
Sigma-Aldrich
透明质酸 钠盐 来源于马链球菌, mol wt 70,000-120,000
Sigma-Aldrich
透明质酸 钠盐 来源于马链球菌, mol wt 2,000,000-2,200,000
Sigma-Aldrich
透明质酸 钠盐 来源于马链球菌, mol wt 50,000-90,000
Sigma-Aldrich
透明质酸 钠盐 来源于马链球菌, mol wt 15,000-30,000
Sigma-Aldrich
透明质酸 钠盐 来源于马链球菌, mol wt 120,000-350,000